May 10, 2022: Pfizer announced its decision of acquiring Biohaven Pharmaceuticals, the maker of NURTEC ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults.
January 13, 2022: AstraZeneca joins hand with Scorpian Therapeutics to develop and commercialize novel cancer treatments.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?